Michael D Rizzari
Overview
Explore the profile of Michael D Rizzari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
125
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Martins P, Rizzari M, Ghinolfi D, Jochmans I, Attia M, Jalan R, et al.
Transplantation
. 2021 Mar;
105(4):796-815.
PMID: 33760791
Background: Recent trials in liver machine perfusion (MP) have revealed unique challenges beyond those seen in most clinical studies. Correct trial design and interpretation of data are essential to avoid...
2.
Rizzari M, Safwan M, Sobolic M, Kitajima T, Collins K, Yoshida A, et al.
Transplantation
. 2020 Mar;
105(2):363-371.
PMID: 32217946
Background: Portal vein thrombosis (PVT) makes the technical aspect of liver transplantation challenging and also affects outcomes. Our aim was to study impact of PVT grade and postreperfusion portal flow...
3.
Takahashi K, Nagai S, Collins K, Safwan M, Rizzari M, Schnickel G, et al.
Clin Transplant
. 2019 Aug;
33(10):e13690.
PMID: 31400156
Appropriate graft regeneration after living donor liver transplantation (LDLT) is crucial to avoid small-for-size syndrome. We enrolled 44 recipients who underwent ABO-identical/compatible LDLT from December 2007 to August 2016 and...
4.
Sulejmani N, Nagai S, Safwan M, Rizzari M, Raoufi M, Abouljoud M, et al.
Pharmacotherapy
. 2018 Feb;
38(4):470-475.
PMID: 29457839
Background: Adenoviruses are double-stranded DNA viruses that typically cause mild self-limiting respiratory, ocular, and gastrointestinal infections. In immunocompromised patients, especially transplant recipients, the infection can be severe, with dissemination and...
5.
Takahashi K, Nagai S, Putchakayala K, Safwan M, Gosho M, Li A, et al.
Transpl Int
. 2017 Jun;
30(10):1032-1040.
PMID: 28605573
Biliary stricture is a common cause of morbidity after liver transplantation (LT). This study aimed to determine the risk factors for post-transplant biliary anastomotic strictures (BAS), focusing on perioperative platelet...
6.
Takahashi K, Nagai S, Putchakayala K, Safwan M, Li A, Kane W, et al.
Clin Transplant
. 2016 Dec;
31(3).
PMID: 27992667
Background: The positive impact of platelets has been recently implicated in liver transplantation (LT). The aim of this study was to determine the risk factors for graft loss and mortality...
7.
Weegman B, Kumar Sajja V, Suszynski T, Rizzari M, Scott Iii W, Kitzmann J, et al.
J Diabetes Res
. 2016 Nov;
2016:6162970.
PMID: 27843954
Islet transplantation (ITx) is an emerging and promising therapy for patients with uncontrolled type 1 diabetes. The islet isolation and purification processes require exposure to extended cold ischemia, warm-enzymatic digestion,...
8.
Scalea J, Redfield R, Rizzari M, Bennett R, Anderson M, Anderson J, et al.
Ann Surg
. 2015 Jul;
263(2):211-6.
PMID: 26181480
Objective: The objective of this study was to determine the fate of patients who attempted to donate organs after circulatory death (DCD) using a standardized DCD protocol. Background: Successful donation...
9.
Weegman B, Suszynski T, Scott 3rd W, Ferrer Fabrega J, Avgoustiniatos E, Anazawa T, et al.
Xenotransplantation
. 2014 Jul;
21(6):574-81.
PMID: 25040217
Porcine islet xenotransplantation is a promising alternative to human islet allotransplantation. Porcine pancreas cooling needs to be optimized to reduce the warm ischemia time (WIT) following donation after cardiac death,...
10.
Suszynski T, Rizzari M, Gillingham K, Rheault M, Kraszkiewicz W, Matas A, et al.
Clin Transplant
. 2013 May;
27(3):472-80.
PMID: 23647497
Hypertension (HTN) is common in pediatric recipients following kidney transplantation (KT). We retrospectively assessed the impact of HTN on long-term (>10-yr) outcomes in pediatric KT recipients (aged < 18 yr)...